Walleye Capital LLC Crinetics Pharmaceuticals, Inc. Call Options Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$43.83 - $54.98 $1.34 Million - $1.68 Million
-30,600 Reduced 87.68%
4,300 $219,000
Q2 2024

Aug 14, 2024
BUY
$42.12 - $51.91 $850,824 - $1.05 Million
20,200 Added 137.41%
34,900 $1.56 Million
Q1 2024

May 15, 2024
BUY
$34.76 - $46.81 $434,500 - $585,125
12,500 Added 568.18%
14,700 $688,000
Q4 2023

Feb 14, 2024
BUY
$25.62 - $37.07 $56,364 - $81,554
2,200 New
2,200 $78,000

Others Institutions Holding CRNX

# of Institutions
241
Shares Held
79.6M
Call Options Held
23.3K
Put Options Held
44.3K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.94B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email